AU5006499A - Compositions and methods for the treatment or prevention of pulmonary infections - Google Patents

Compositions and methods for the treatment or prevention of pulmonary infections

Info

Publication number
AU5006499A
AU5006499A AU50064/99A AU5006499A AU5006499A AU 5006499 A AU5006499 A AU 5006499A AU 50064/99 A AU50064/99 A AU 50064/99A AU 5006499 A AU5006499 A AU 5006499A AU 5006499 A AU5006499 A AU 5006499A
Authority
AU
Australia
Prior art keywords
prevention
compositions
treatment
methods
pulmonary infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50064/99A
Inventor
Conway C. Chang
John C. Fiddes
Henry Fuchs
David J. Loury
Deborah A. Steinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ardea Biociences Inc
Original Assignee
IntraBiotics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IntraBiotics Pharmaceuticals Inc filed Critical IntraBiotics Pharmaceuticals Inc
Publication of AU5006499A publication Critical patent/AU5006499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU50064/99A 1998-07-23 1999-07-23 Compositions and methods for the treatment or prevention of pulmonary infections Abandoned AU5006499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12144798A 1998-07-23 1998-07-23
US09121447 1998-07-23
PCT/US1999/016739 WO2000004915A1 (en) 1998-07-23 1999-07-23 Compositions and methods for the treatment or prevention of pulmonary infections

Publications (1)

Publication Number Publication Date
AU5006499A true AU5006499A (en) 2000-02-14

Family

ID=22396796

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50064/99A Abandoned AU5006499A (en) 1998-07-23 1999-07-23 Compositions and methods for the treatment or prevention of pulmonary infections

Country Status (2)

Country Link
AU (1) AU5006499A (en)
WO (1) WO2000004915A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX352760B (en) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Methods for treating intrapulmonary infections.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (en) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
MX2017016251A (en) * 2015-07-02 2018-04-20 Dana Farber Cancer Inst Inc Stabilized anti-microbial peptides.
CN109069578A (en) 2016-02-29 2018-12-21 达纳-法伯癌症研究所股份有限公司 For treating the intracellular targeted antimicrobial peptides of the stitching of infection
CA3060561A1 (en) * 2017-04-19 2018-10-25 The Regents Of The University Of Colorado, A Body Corporate Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-polar face analogs
US11325955B2 (en) 2017-07-19 2022-05-10 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins

Also Published As

Publication number Publication date
WO2000004915A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
HK1040944A1 (en) Methods and compositions for the prevention and treatment of anemia
EP1143956A3 (en) Compositions and methods for the treatment of anorectal disorders
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2951299A (en) Disinfecting compositions and processes for disinfecting surfaces
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
AU2001239052A1 (en) Compositions for prevention and treatment of dementia
EP1076547A4 (en) Derivatives of arabinogalactan and compositions including the same
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU4061597A (en) Treatment of the common cold or allergic rhinitis
AU1509999A (en) Herbal drug composition for the prevention and treatment of dementia
AU2469599A (en) Methods for the prevention and treatment of fibrosis and sclerosis
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU1556497A (en) Agents for the treatment and prevention of aids
AU3065999A (en) Compositions and methods for treatment of asthma
WO2001093878A8 (en) Bismuth compounds for the treatment and prevention of mucositis
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU3103097A (en) Compositions and methods for the treatment of chronic infections
AU2002228500A1 (en) Methods and compositions for reducing or preventing onset of milk fever
AU2000265105A1 (en) Methods and compositions for the prevention and treatment of syndrome x

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase